Customize
Quick Links
Specialties

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669 for 1.5 Contact Hours.

Repurposing Statement

If you previously participated and received credit for the live CME/CE-certified webcast, Miami Breast Cancer Conference®: Attendee Tumor Board, which was held October 27, 2017, in Cranbury, New Jersey, please note that you will not receive credit for completing this activity. Participants who take part in an identical activity, even to validate learning or to clarify specific topics, cannot claim, nor will Physicians’ Education Resource®, LLC award, duplicate credit for the activity.

Source of Funding

This activity is funded entirely by Physicians’ Education Resource®, LLC.

Miami Breast Cancer Conference®: Attendee Tumor Board Online

Release Date: November 30, 2017
Expiration Date: November 30, 2018
Media: Internet - based

 

Activity Overview

The Miami Breast Cancer Conference®: Attendee Tumor Board is an exciting supplemental activity of the annual Miami Breast Cancer Conference® that extends the case-based based format of the live conference. This tumor board aired on October 27, 2017, as a live webcast led by world-renowned breast cancer experts Patrick I. Borgen, MD; Elizabeth A. Mittendorf, MD, PhD; Hope S. Rugo, MD; and Debu Tripathy, MD. This enduring CME activity is an archive of the live broadcast that has been edited into modules for ease of access.

Since 1982, the Miami Breast Cancer Conference® has radically transformed the ability of physicians and healthcare professionals to provide world-class care for their patients through engaging and practice-changing educational programming that provides up-to-the-minute advances in breast cancer oncology. It is designed to bring expert perspectives on late-breaking research findings, controversies, and other breakthroughs to our attendees. Following 35 years of such innovation and leadership, Miami Breast Cancer Conference® continues to refine and improve its approach toward breast cancer education. Supplemental activities such as these are created to provide essential updates so that practitioners can maintain state-of-the-art care for their patients year-round.

The Miami Breast Cancer Conference®: Attendee Tumor Board brings conference-caliber education to the convenience of your screen!

Source of Funding

This activity is funded entirely by Physicians’ Education Resource®, LLC.

CME/CE Activity Table of Contents

  • Introduction
  • Case 1. Surgical and Systemic Therapy for Metastatic HER2+ Breast Cancer After Response to Neoadjuvant Therapy
  • Case 2. Role of Local Control in Stage IV Breast Cancer
  • Case 3. HR+, 2.3-cm, Node-Negative Breast Cancer
  • Case 4. BRCA1+, Node-Positive TNBC: Status Residual Disease, Post-Dose-Dense AC-Paclitaxel Followed by Bilateral Mastectomy
  • Case 5. HR+, HER2-Negative, Metastatic Ductal Carcinoma With Pulmonary Embolus on Hormone Therapy
  • Case 6. Disease Recurrence 15 Years After AC-T Chemotherapy: Weakly HR+, HER2-Negative, Grade 2 IDC
  • Case 7. Treatment-Naïve, High-Grade, Metastatic TNBC With Node, Bone, and Lung Involvement
  • Case 8. Older Patient With Significant Comorbidity and Newly Diagnosed Localized IDC
  • Key Takeaways

Instructions for This Activity and Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “educational content/video files” will be available for your reference.
  • In order to receive a cme/ce certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a cme/ce certificate upon completion of these steps.

Target Audience

This educational activity is directed toward medical oncologists, surgical oncologists, and radiation oncologists involved in the treatment and management of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of breast cancer may also participate.

Learning Objectives

At the conclusion of this activity, you should be better prepared to:

  • Assess how recent evidence and guidelines can be applied to overall treatment planning, including loco-regional and systemic treatment considerations for patients with breast cancer.
  • Describe the evolving role of molecular testing to optimize clinical decision making in breast cancer treatment settings.
  • Identify patients who might benefit from participation in ongoing breast cancer clinical trials.
  • Explain how disease- and patient-related factors can be used to guide breast cancer management, including proactive identification and mitigation of treatment-related toxicities.

Faculty, Staff, and Planners' Disclosures

Activity Chair

Patrick I. Borgen, MD
Chair, Department of Surgery
Maimonides Medical Center
Brooklyn, NY
 
 

Disclosure: Speaker’s Bureau: Genomic Health, Inc., Genentech, Pacira, Inc.

Faculty

Elizabeth A. Mittendorf, MD, PhD
Professor
Department of Breast Surgical Oncology
The University of Texas MD Anderson Cancer Center
Houston, TX
 

Disclosure: Grant/Research Support: Galena Biopharma, Antigen Express, Genentech, AstraZeneca, EMD-Serono. (Dr Mittendorf does not personally receive funding; her institution receives funding to support the conduct of clinical trials investigating vaccines owned by these companies.)

Hope S. Rugo, MD
Professor of Medicine
Director, Breast Oncology and Clinical Trials Education
University of California, San Francisco
Helen Diller Family Comprehensive Cancer Center
San Francisco, CA

Disclosure: Grants/Research Support: Genentech/Roche, Novartis, Merck, Pfizer, OBI, Macrogenics, Lilly, Eisai. (For research studies, all funding goes to UCSF regents.)

Debu Tripathy, MD
Professor and Chair
Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, TX
 

Disclosure: Grant/Research Support: Novartis; Consultant: Nektar, Novartis, Puma

The staff of PER® have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.

CME/CE Provider Contact Information

Physicians’ Education Resource®, LLC
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
info@gotoper.com

Hardware And Software Requirements 

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)

  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Minimum System Requirements (Mac OS)

  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise






Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
     12
3456789
10111213141516
17181920212223
24252627282930
31
Filter By